000906227 001__ 906227
000906227 005__ 20230123110558.0
000906227 0247_ $$2doi$$a10.1111/jon.12971
000906227 0247_ $$2ISSN$$a1051-2284
000906227 0247_ $$2ISSN$$a1552-6569
000906227 0247_ $$2Handle$$a2128/31549
000906227 0247_ $$2altmetric$$aaltmetric:122166058
000906227 0247_ $$2pmid$$apmid:35099094
000906227 0247_ $$2WOS$$aWOS:000749658000001
000906227 037__ $$aFZJ-2022-01305
000906227 082__ $$a610
000906227 1001_ $$00000-0002-9077-8793$$aFerrea, Stefano$$b0$$eCorresponding author
000906227 245__ $$aBrain volume patterns in corticobasal syndrome versus idiopathic Parkinson's disease
000906227 260__ $$aBerlin [u.a.]$$bWiley-Blackwell$$c2022
000906227 3367_ $$2DRIVER$$aarticle
000906227 3367_ $$2DataCite$$aOutput Types/Journal article
000906227 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1658740266_20804
000906227 3367_ $$2BibTeX$$aARTICLE
000906227 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000906227 3367_ $$00$$2EndNote$$aJournal Article
000906227 520__ $$aAbstractBackground and purpose: Patients with a corticobasal syndrome (CBS) present a rare form of atypical parkinsonism characterized by asymmetric clinical symptoms and progressive motor and nonmotor impairment, such as apraxia, alien limb phenomenon, aphasia, myoclonus, dystonia, and cognitive impairment. At early stages, clinical differentiation between CBS and idiopathic Parkinson's disease (IPD) can be challenging.Methods: Using high-resolution T1-weighted images and voxel-based morphometry (VBM), we sought to identify disease-specific patterns of brain atrophy in a small sample of CBS and IPD patients at early stages of disease. We acquired MR images of 17 patients diagnosed with CBS and compared them with MR images of 17 subjects affected by IPD. Images were preprocessed and analyzed using VBM.Results: When compared to each other, the CBS and IPD patients of our cohort showed differences in regional gray and white matter volume depending on the diagnosis, specifically in the superior longitudinal fascicle.Conclusions: In our small patients' group, VBM was able to detect changes in regional gray and white matter volume between patients affected by CBS and patients with IPD as early as 1.5-2 years after the onset of the first motor symptoms.Keywords: Corticobasal syndrome; brain atrophy; idiopathic Parkinson syndrome; voxel-based morphometry.
000906227 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000906227 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000906227 7001_ $$aJunker, Frederick Benjamin$$b1
000906227 7001_ $$aHartmann, Christian Johannes$$b2
000906227 7001_ $$aDinkelbach, Lars$$b3
000906227 7001_ $$0P:(DE-Juel1)131678$$aEickhoff, Simon B.$$b4$$ufzj
000906227 7001_ $$aMoldovan, Alexia Sabine$$b5
000906227 7001_ $$aSüdmeyer, Martin$$b6
000906227 7001_ $$aSchnitzler, Alfons$$b7
000906227 7001_ $$aSchmidt-Wilcke, Tobias$$b8
000906227 773__ $$0PERI:(DE-600)2035400-9$$a10.1111/jon.12971$$gp. jon.12971$$n4$$p720-727$$tJournal of neuroimaging$$v32$$x1051-2284$$y2022
000906227 8564_ $$uhttps://juser.fz-juelich.de/record/906227/files/Journal%20of%20Neuroimaging%20-%202022%20-%20Ferrea%20-%20Brain%20volume%20patterns%20in%20corticobasal%20syndrome%20versus%20idiopathic%20Parkinson%20s.pdf
000906227 8564_ $$uhttps://juser.fz-juelich.de/record/906227/files/Manuscript_revision_6_sf_fj%20Stefano%20Ferrea.docx$$yPublished on 2022-01-31. Available in OpenAccess from 2023-01-31.$$zStatID:(DE-HGF)0510
000906227 909CO $$ooai:juser.fz-juelich.de:906227$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000906227 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131678$$aForschungszentrum Jülich$$b4$$kFZJ
000906227 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000906227 9141_ $$y2022
000906227 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000906227 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000906227 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-01-28$$wger
000906227 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000906227 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROIMAGING : 2021$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-15
000906227 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-15
000906227 920__ $$lyes
000906227 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000906227 980__ $$ajournal
000906227 980__ $$aVDB
000906227 980__ $$aUNRESTRICTED
000906227 980__ $$aI:(DE-Juel1)INM-7-20090406
000906227 9801_ $$aFullTexts